% Expired Patents = 50.0

CIPO Patents = 1

EPO Patents = 3

Trademarks = 1

Forward Citations = 21

Loading Chart...

15 inventors (with patents filed for the assignee):

Stefan Knackmuss (4 out of 15 patents)

Melvyn Little (3 out of 23 patents)

Uwe Reusch (2 out of 19 patents)

4. Karlheinz Peter (2 out of 10 patents)

5. Peter Röttgen (2 out of 6 patents)

6. Peter Roettgen (2 out of 2 patents)

7. Meike Schwarz (2 out of 2 patents)

8. Fabrice Le Gall (1 out of 8 patents)

9. Karin Hoffmann (1 out of 4 patents)

10. Sergey Kipriyanov (1 out of 5 patents)

11. Claudia Linhard (1 out of 1 patent)

12. Vera Mick (1 out of 1 patent)

13. Claudia Buettner (1 out of 1 patent)

14. Clémence Rey (1 out of 1 patent)

15. Claudia Büttner (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8455627 - Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa (2013-06-04),

2. 7901677 - Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types (2011-03-08),

3. 7812136 - Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIa (2010-10-12),

4. 7507797 - Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof (2009-03-24),

Company Overview

Affimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing cancer immunotherapies using its innovative platform of bispecific antibodies. The company's pipeline includes both solid tumor and blood cancer candidates, with a commitment to bringing new treatment options to patients with unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#65 in Heidelberg

#7,035 in Germany

Heidelberg, Germany

Affimed Therapeutics, Ag

Forward Citations = 21

15 inventors:

Stefan Knackmuss (4 out of 15 patents)

Melvyn Little (3 out of 23 patents)

Uwe Reusch (2 out of 19 patents)

4. Karlheinz Peter (2 out of 10 patents)

5. Peter Röttgen (2 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Affimed Therapeutics, Ag. Retrieved from https://idiyas.com/company/affimed-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]